Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)

v3.20.2
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Totals 5,345,321 3,405,142 5,345,321 3,405,142
Options to Purchase Common Stock [Member]        
Totals 1,060,254 1,585,634 1,060,254 1,585,634
Series H-1, H-3, H-4, H-5, I, J, pre-merger AYRO and Merger Common Stock Purchase Warrants [Member]        
Totals 4,006,205 341,941 4,006,205 341,941
Series H, H-3, H-6, and Pre-merger AYRO Seed Preferred Stock [Member]        
Totals 278,862 1,477,567 278,862 1,477,567